ALLZITAL Drug Patent Profile
✉ Email this page to a colleague
When do Allzital patents expire, and when can generic versions of Allzital launch?
Allzital is a drug marketed by Larken Labs Inc and is included in one NDA.
The generic ingredient in ALLZITAL is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLZITAL?
- What are the global sales for ALLZITAL?
- What is Average Wholesale Price for ALLZITAL?
Summary for ALLZITAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Drug Prices: | Drug price information for ALLZITAL |
| DailyMed Link: | ALLZITAL at DailyMed |
Pharmacology for ALLZITAL
| Drug Class | Barbiturate |
US Patents and Regulatory Information for ALLZITAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Larken Labs Inc | ALLZITAL | acetaminophen; butalbital | TABLET;ORAL | 203484-001 | Dec 4, 2015 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
